Ocugen is updating its Retina Scientific Advisory Board, while Peter K Kaiser holds chairs at Cleveland Clinic and Ophthalmic Consultants of Boston.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ocugen is updating its Retina Scientific Advisory Board, while Peter K Kaiser holds chairs at Cleveland Clinic and Ophthalmic Consultants of Boston.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ocugen
biopharmaceutical company
Nothing else this week.
-
Cleveland Clinic
nonprofit multispecialty academic medical center based in Cleveland, Ohio, United States
Coverage
Newest first; wire copies grouped- GlobeNewswireOcugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: O